As of January 23, 2025, Vaxxinity (VAXX) has a market cap of $63,392 Dollars USD. According to our data, Vaxxinity is ranked No.9308 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $63,392 Dollars |
-88.77%
|
Dec 31, 2024 | $0.56 M |
-99.41%
|
Dec 29, 2023 | $95.97 M |
-39.29%
|
Dec 30, 2022 | $0.16 B |
-75.04%
|
Dec 31, 2021 | $0.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Valneva SE
VALN
|
$0.38 B |
0.000 M
|
France
|
Market Cap | = | VAXX Stock Price | * | VAXX Shares Outstanding |
= | $0.00 | * | 0.11 B | |
= | $63,392 Dollars |